PMC6378798_01
Trend in calcium level during the course of treatment with patiromer acetate.
CRIN2019-3507407.001.jpg
PMC6378798_01_CRIN2019-3507407.001.jpg
fig1
On follow-up after an additional 30 days, calcium returned even higher, 11.6 mg/dL (Figure 1), and potassium even lower, 4.6 mmol/L (Figures 2 and 3).
Trend in potassium level during the course of treatment with patiromer acetate.
CRIN2019-3507407.002.jpg
PMC6378798_01_CRIN2019-3507407.002.jpg
fig2
On follow-up after an additional 30 days, calcium returned even higher, 11.6 mg/dL (Figure 1), and potassium even lower, 4.6 mmol/L (Figures 2 and 3).
Trend in calcium and potassium level during the course of treatment with patiromer acetate. Arrows indicate start and stop date of patiromer acetate.
CRIN2019-3507407.003.jpg
PMC6378798_01_CRIN2019-3507407.003.jpg
fig3
On follow-up after an additional 30 days, calcium returned even higher, 11.6 mg/dL (Figure 1), and potassium even lower, 4.6 mmol/L (Figures 2 and 3).